Proteomic analysis of lysine 2-hydroxyisobutyryl in SLE reveals protein modification alteration in complement and coagulation cascades and platelet activation Pathways

• Published in: BMC medical genomics Vol. 16; no. 1; pp. 1 - 247
• Main Authors: Kuang, Chaoying, Li, Dandan, Zhou, Xianqing, Lin, Hua, Zhang, Ruohan, Xu, Huixuan, Huang, Shaoying, Tang, Fang, Liu, Fanna, Tang, Donge, Dai, Yong
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 16-10-2023; BioMed Central; BMC
• Subjects: 2-Hydroxyisobutyrylation; Activation; Autoimmune diseases; Bioinformatics; Blood clotting; Blood platelets; Cell adhesion & migration; Coagulation; Complement system; Development and progression; Disease; Genetic aspects; Health aspects; Immunological research; Leukocytes (mononuclear); Liquid chromatography; Localization; Lysine; Mass spectroscopy; Metabolic disorders; Pathogenesis; Peptides; Peripheral blood mononuclear cells; Platelets; Post-translation; Post-translational modification; Protein post-translational modification; Proteins; Proteomic; Proteomics; Research ethics; Software; Systemic lupus erythematosus; Translation; China
• ISSN: 1755-8794; 1755-8794
• DOI: 10.1186/s12920-023-01656-y

Post-translational modifications (PTMs) are considered to be an important factor in the pathogenesis of Systemic lupus erythematosus (SLE). Lysine 2-hydroxyisobutyryl (Khib), as an emerging post-translational modification of proteins, is involved in some important biological metabolic activities. However, there are poor studies on its correlation with diseases, especially SLE. We performed quantitative, comparative, and bioinformatic analysis of Khib proteins in Peripheral blood mononuclear cells (PBMCs) of SLE patients and PBMCs of healthy controls. Searching for pathways related to SLE disease progression and exploring the role of Khib in SLE. Khib levels in SLE patients and healthy controls were compared based on liquid chromatography tandem mass spectrometry, then proteomic analysis was conducted. Compared with healthy controls, Khib in SLE patients was up-regulated at 865 sites of 416 proteins and down-regulated at 630 sites of 349 proteins. The site abundance, distribution and function of Khib protein were investigated further. Bioinformatics analysis showed that Complement and coagulation cascades and Platelet activation in immune-related pathways were significantly enriched, suggesting that differentially modified proteins among them may affect SLE. Khib in PBMCs of SLE patients was significantly up- or down-regulated compared with healthy controls. Khib modification of key proteins in the Complement and coagulation cascades and Platelet activation pathways affects platelet activation and aggregation, coagulation functions in SLE patients. This result provides a new direction for the possible significance of Khib in the pathogenesis of SLE patients.